 |
16 Diseases |  |
3 Trials |
|
3 Trials |  |
683 News |  |
| «1234567 |
- LENZ (lenzilumab) / Humanigen
Trial suspension: Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML) (clinicaltrials.gov) - Nov 17, 2015
P1, N=31, Suspended, Sponsor: KaloBios Pharmaceuticals
Recruiting --> Suspended
- LENZ (lenzilumab) / Humanigen
Enrollment open: Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML) (clinicaltrials.gov) - Oct 27, 2015
P1, N=31, Recruiting, Sponsor: KaloBios Pharmaceuticals
Recruiting --> Suspended Not yet recruiting --> Recruiting
- | LENZ (lenzilumab) / Humanigen
New P1 trial: Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML) (clinicaltrials.gov) - Sep 10, 2015
P1, N=31, Not yet recruiting, Sponsor: KaloBios Pharmaceuticals
- |||| LENZ (lenzilumab) / Humanigen
Trial completion: Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids (clinicaltrials.gov) - Feb 25, 2014
P2, N=160, Completed, Sponsor: KaloBios Pharmaceuticals
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- LENZ (lenzilumab) / Humanigen
Trial termination: Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis (clinicaltrials.gov) - Sep 20, 2012
P2, N=9, Terminated, Sponsor: KaloBios Pharmaceuticals
Active, not recruiting --> Completed Completed --> Terminated; Program refocus
- LENZ (lenzilumab) / Humanigen
Trial initiation date: Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis (clinicaltrials.gov) - Sep 20, 2012
P2, N=9, Terminated, Sponsor: KaloBios Pharmaceuticals
Completed --> Terminated; Program refocus Initiation date: Oct 2009 --> Jan 2010
- ||||| LENZ (lenzilumab) / Humanigen
New P2 trial: Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids (clinicaltrials.gov) - May 20, 2012
P2, N=160, Completed, Sponsor: KaloBios Pharmaceuticals